A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780
Publication
, Journal Article
Savarese, D; Taplin, ME; Halabi, S; Hars, V; Kreis, W; Vogelzang, N
Published in: SEMINARS IN ONCOLOGY
October 1, 1999
Duke Scholars
Published In
SEMINARS IN ONCOLOGY
ISSN
0093-7754
Publication Date
October 1, 1999
Volume
26
Issue
5
Start / End Page
39 / 44
Publisher
W B SAUNDERS CO
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Savarese, D., Taplin, M. E., Halabi, S., Hars, V., Kreis, W., & Vogelzang, N. (1999). A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780. SEMINARS IN ONCOLOGY, 26(5), 39–44.
Savarese, D., M. E. Taplin, S. Halabi, V. Hars, W. Kreis, and N. Vogelzang. “A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780.” SEMINARS IN ONCOLOGY 26, no. 5 (October 1, 1999): 39–44.
Savarese D, Taplin ME, Halabi S, Hars V, Kreis W, Vogelzang N. A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780. SEMINARS IN ONCOLOGY. 1999 Oct 1;26(5):39–44.
Savarese, D., et al. “A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780.” SEMINARS IN ONCOLOGY, vol. 26, no. 5, W B SAUNDERS CO, Oct. 1999, pp. 39–44.
Savarese D, Taplin ME, Halabi S, Hars V, Kreis W, Vogelzang N. A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780. SEMINARS IN ONCOLOGY. W B SAUNDERS CO; 1999 Oct 1;26(5):39–44.
Published In
SEMINARS IN ONCOLOGY
ISSN
0093-7754
Publication Date
October 1, 1999
Volume
26
Issue
5
Start / End Page
39 / 44
Publisher
W B SAUNDERS CO
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis